Inflammation and colon cancer
- PMID: 20420949
- DOI: 10.1053/j.gastro.2010.01.058
Inflammation and colon cancer
Abstract
The connection between inflammation and tumorigenesis is well-established and in the last decade has received a great deal of supporting evidence from genetic, pharmacological, and epidemiological data. Inflammatory bowel disease is an important risk factor for the development of colon cancer. Inflammation is also likely to be involved with other forms of sporadic as well as heritable colon cancer. The molecular mechanisms by which inflammation promotes cancer development are still being uncovered and could differ between colitis-associated and other forms of colorectal cancer. Recent work has elucidated the role of distinct immune cells, cytokines, and other immune mediators in virtually all steps of colon tumorigenesis, including initiation, promotion, progression, and metastasis. These mechanisms, as well as new approaches to prevention and therapy, are discussed in this review.
Similar articles
-
Large Bowel Genetic Background and Inflammatory Processes in Carcinogenesis--Systematic Review.Adv Clin Exp Med. 2015 Jul-Aug;24(4):555-63. doi: 10.17219/acem/31239. Adv Clin Exp Med. 2015. PMID: 26469098 Review.
-
Inflammatory bowel disease and inflammation-associated colon cancer: partners in crime.Curr Drug Targets. 2008 May;9(5):360. doi: 10.2174/138945008784221134. Curr Drug Targets. 2008. PMID: 18473762 No abstract available.
-
Inflammation and colorectal cancer: colitis-associated neoplasia.Semin Immunopathol. 2013 Mar;35(2):229-44. doi: 10.1007/s00281-012-0352-6. Epub 2012 Nov 16. Semin Immunopathol. 2013. PMID: 23161445 Free PMC article. Review.
-
Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.Eur J Gastroenterol Hepatol. 2013 Mar;25(3):271-81. doi: 10.1097/MEG.0b013e32835b5803. Eur J Gastroenterol Hepatol. 2013. PMID: 23169309 Review.
-
Inflammation in sporadic colorectal cancer.Arch Iran Med. 2012 Mar;15(3):166-70. Arch Iran Med. 2012. PMID: 22369306 Review.
Cited by
-
Positional mapping and candidate gene analysis of the mouse Ccs3 locus that regulates differential susceptibility to carcinogen-induced colorectal cancer.PLoS One. 2013;8(3):e58733. doi: 10.1371/journal.pone.0058733. Epub 2013 Mar 14. PLoS One. 2013. PMID: 23516545 Free PMC article.
-
Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma.Sci Rep. 2020 Oct 12;10(1):16988. doi: 10.1038/s41598-020-73965-6. Sci Rep. 2020. PMID: 33046752 Free PMC article.
-
Toll-Like Receptor 3 as a Recurrence Risk Factor and a Potential Molecular Therapeutic Target in Colorectal Cancer.Clin Exp Gastroenterol. 2020 Oct 2;13:427-438. doi: 10.2147/CEG.S252157. eCollection 2020. Clin Exp Gastroenterol. 2020. PMID: 33061521 Free PMC article.
-
Relationship Between Chronic Inflammation and the Stage and Histopathological Size of Colorectal Carcinoma.Med Arch. 2016 Apr;70(2):104-7. doi: 10.5455/medarh.2016.70.104-107. Epub 2016 Apr 1. Med Arch. 2016. PMID: 27147782 Free PMC article.
-
Extracellular Vesicles and Immune System Function: Exploring Novel Approaches to Colorectal Cancer Immunotherapy.Biomedicines. 2024 Jul 3;12(7):1473. doi: 10.3390/biomedicines12071473. Biomedicines. 2024. PMID: 39062046 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical